Please login to the form below

Not currently logged in
Email:
Password:

Lucid bolsters client services and delivery teams

Helen Hutton, David Burton and Clare Bibby join the agency

Lucid GroupMedical communications agency Lucid Group has appointed Helen Hutton as its business unit director for its specialist strategic health communications and medical education arm Leading Edge.

Hutton will be based in the Macclesfield office and she will oversee the team who are spread across both the North West and Buckinghamshire sites.

She said: “I’m thrilled to be joining such a progressive organisation.

“Their pioneering and human centric approach to med comms is refreshing.”

Also joining the Macclesfield office is David Burton, who becomes its programme director.

He said: “I’ve always admired Lucid’s approach to medical education – delivering pioneering programmes that achieve measureable behaviour change outcomes.

“I was also drawn to its strong team culture; the chance to be part of the rapidly growing team in the North West was an opportunity I couldn’t miss.”

Completing the line-up is Clare Bibby, who joins the group as a senior account manager.

She said: “I’m looking forward to putting Lucid’s behaviour-change methodology into practice and make a different to patients’ lives.”

6th June 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Collected Group

Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...